Amryt Pharma PLC (LSE:AMYT) - Share price


Stock Report

Amryt Pharma PLC AMYT

Last Price
GBX115.00

Day Change
-1.00|-0.86%

As of 22/11/2019
10:59:48 GMT | GBX
Minimum 15 Minutes Delay.

Last Close116.00p
Day Range114.00 - 115.00
Mkt Cap177.30Mil
52-Wk Range69.90 - 143.00
Yield %-
ISINGB00BKLTQ412
Volume4,094
P/E-5.95
P/S3.64
P/CF-4.04

Share Price

Total Returns 21/11/2019

 Chg (%)  
More ...
Amryt Pharma PLC-0.43 
FTSE 100 TR GBP1.43
 
Financials
201620172018
More ...
Income Statement
Turnover1.3512.7814.45
Operating Profit-5.85-14.21-15.25
Net Profit-7.80-26.14-25.78
Reported EPS-0.29-0.70-0.56
Balance Sheet
Current Assets11.5826.3216.86
Non Current Assets53.7053.7753.79
Total Assets65.2980.0970.64
Current Liabilities3.559.8010.53
Total Liabilities---
Total Equity33.0421.89-3.23
Cash Flow
Operating Cash Flow-6.11-11.86-13.07
Net Change in Cash8.1012.17-10.50
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/08/2019PurchaseMr. Raymond Thomas Stafford90.00918,273826,446.00

Company Profile

Amryt Pharma PLC is a specialty pharmaceutical company. The company is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 17/04/2020

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-40.54
Op Mrgn-1.06
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, ChairmanMr. Raymond Thomas Stafford
Company SecretaryMr. Rory Peter Nealon
Executive Director, Chief Executive OfficerDr. Joseph Amrit Wiley
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.